Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems
Julie Moltke, Chandni Hindocha
Journal of Cannabis Research (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals
Christopher A. Legare, Wesley M. Raup‐Konsavage, Kent E. Vrana
Pharmacology (2022) Vol. 107, Iss. 3-4, pp. 131-149
Open Access | Times Cited: 172
Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial
C. Austin Zamarripa, Tory R. Spindle, Renuka Surujunarain, et al.
JAMA Network Open (2023) Vol. 6, Iss. 2, pp. e2254752-e2254752
Open Access | Times Cited: 47
Cannabidiol‐associated hepatotoxicity: A systematic review and meta‐analysis
Lindsay A. Lo, April Christiansen, Lauren Eadie, et al.
Journal of Internal Medicine (2023) Vol. 293, Iss. 6, pp. 724-752
Open Access | Times Cited: 35
The therapeutic potential of purified cannabidiol
Saoirse E. O’Sullivan, Sanne Jensen, Gitte Nykjaer Nikolajsen, et al.
Journal of Cannabis Research (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 29
Cannabidiol for moderate–severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing
Andrea J. Narayan, Luke A. Downey, Sarah Rose, et al.
Journal of Clinical Sleep Medicine (2024) Vol. 20, Iss. 5, pp. 753-763
Closed Access | Times Cited: 10
Novel rapid treatment options for adolescent depression
Sandra Ledesma‐Corvi, Jordi Jornet-Plaza, Laura Gálvez‐Melero, et al.
Pharmacological Research (2024) Vol. 201, pp. 107085-107085
Open Access | Times Cited: 9
Cannabidiol and brain function: current knowledge and future perspectives
Moniek Schouten, Sebastiaan Dalle, Dante Mantini, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 8
Validated LC-MS/MS methodology for the quantification of CBD, trace level THCA and UK controlled cannabinoids (Δ9THC, Δ8THC, CBN and THCV) in food samples
Tabatha Hambidge, Ralph G. Nash, Steve Corless, et al.
Analytical Methods (2025)
Open Access | Times Cited: 1
Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study
Nicholas Frane, Erik Stapleton, Cesar Iturriaga, et al.
Journal of Cannabis Research (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 38
Adherence, Safety, and Effectiveness of Medical Cannabis and Epidemiological Characteristics of the Patient Population: A Prospective Study
Lihi Bar‐Lev Schleider, Raphael Mechoulam, Inbal Sikorin, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 32
Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions
Jeremy D. Henson, Luis Vitetta, Sean Hall
Inflammopharmacology (2022) Vol. 30, Iss. 4, pp. 1167-1178
Open Access | Times Cited: 30
Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles
Ronit Vogt Sionov, Doron Steinberg
Biomedicines (2022) Vol. 10, Iss. 3, pp. 631-631
Open Access | Times Cited: 28
Effects of Cannabidiol Supplementation on Skeletal Muscle Regeneration after Intensive Resistance Training
Eduard Isenmann, Sebastian Veit, Lynn Starke, et al.
Nutrients (2021) Vol. 13, Iss. 9, pp. 3028-3028
Open Access | Times Cited: 40
Cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder
Jenika Staben, Megan Koch, Keelee Reid, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 14
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
Edward Chesney, Dominic Oliver, Philip McGuire
Psychopharmacology (2021) Vol. 239, Iss. 5, pp. 1179-1190
Open Access | Times Cited: 32
Effects of Oral Cannabidiol on Health and Fitness in Healthy Adults: An 8-Week Randomized Trial
Victoria Flores, Jacob N. Kisiolek, Arjun Ramani, et al.
Nutrients (2023) Vol. 15, Iss. 12, pp. 2664-2664
Open Access | Times Cited: 11
Eight Weeks of Daily Cannabidiol Supplementation Improves Sleep Quality and Immune Cell Cytotoxicity
Jacob N. Kisiolek, Victoria Flores, Arjun Ramani, et al.
Nutrients (2023) Vol. 15, Iss. 19, pp. 4173-4173
Open Access | Times Cited: 11
Patterns of cannabidiol use among marijuana users in the United States
Ji-Yeun Park
Preventive Medicine Reports (2025) Vol. 50, pp. 102985-102985
Open Access
Effectiveness of a Cannabinoids Supplement on Sleep and Mood in Adults With Subthreshold Insomnia: A Randomized Double‐Blind Placebo‐Controlled Crossover Pilot Trial
Heather A. Hausenblas, Stephanie Hooper, Tarah Lynch
Health Science Reports (2025) Vol. 8, Iss. 2
Open Access
Cannabis: Zone Aspects of Raw Plant Components in Sport—A Narrative Review
Corina Flangea, Mihaela Vlad, Roxana Popescu, et al.
Nutrients (2025) Vol. 17, Iss. 5, pp. 861-861
Open Access
The Therapeutic Potential of Cannabidiol in the Management of Temporomandibular Disorders and Orofacial Pain
Karolina Walczyńska-Dragon, Anna Kurek-Górecka, Jakub Fiegler-Rudol, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 328-328
Open Access
Acid-Catalyzed Conversion of Cannabidiol to Tetrahydrocannabinols: En Route to Demystifying Manufacturing Processes and Controlling the Reaction Outcomes
Alex Nivorozhkin, Michael G. Palfreyman
Cannabis and Cannabinoid Research (2025)
Closed Access
A preliminary randomized trial of the safety, tolerability, and clinical effects of hemp-derived cannabidiol in alcohol use disorder
Raeghan L. Mueller, Judith Hooper, Jarrod M. Ellingson, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Use of Cannabidiol in the Management of Insomnia: A Systematic Review
Rylea Ranum, Mary O. Whipple, Ivana T. Croghan, et al.
Cannabis and Cannabinoid Research (2022)
Closed Access | Times Cited: 18
Cannabidiol use and perceptions in France: a national survey
Clémence Casanova, Clémence Ramier, Davide Fortin, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top